lobbying_activities: 1587164

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1587164	d949be25-c821-4795-ba4e-7b123c4a906d	Q3	BROWN RUDNICK LLP	287895	EXELA HOLDINGS, LLC	2014	third_quarter	PHA	Implementation of P.L. 112-144 (FDA Safety and Innovation Act) and P.L. 113 - 54 (Drug Quality and Security Act); Issues relating to ANDA approval	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2014-10-15T15:25:44.860000-04:00